Crescent Biopharma, Inc.
CBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001253689
In the last 90 days, Crescent Biopharma, Inc. insiders filed 1 open-market purchase and 7 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $532.6M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Crescent Biopharma, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- −1 vs. Q3 2021
- Shares held
- 29.7M
- +34.1K (+0.1%) vs. Q3 2021
- Total value
- $42.7M
- −$22.2M (−34.2%) vs. Q3 2021
- New holders
- 5
- 17 more added
- Sold out
- 6
- 14 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 82 | $532.6M |
| Q1 2026 | 63 | $476.6M |
| Q4 2025 | 58 | $285.9M |
| Q3 2025 | 41 | $134.6M |
| Q2 2025 | 30 | $173.5M |
| Q1 2025 | 35 | $6.46M |
| Q4 2024 | 41 | $7.56M |
| Q3 2024 | 36 | $3.00M |
| Q2 2024 | 35 | $7.20M |
| Q1 2024 | 69 | $110.5M |
| Q4 2023 | 58 | $82.8M |
| Q3 2023 | 49 | $52.1M |
| Q2 2023 | 55 | $61.9M |
| Q1 2023 | 54 | $46.6M |
| Q4 2022 | 48 | $83.3M |
| Q3 2022 | 35 | $14.3M |
| Q2 2022 | 37 | $15.8M |
| Q1 2022 | 44 | $31.2M |
| Q4 2021 | 47 | $42.7M |
| Q3 2021 | 48 | $64.9M |
| Q2 2021 | 58 | $72.5M |
| Q1 2021 | 78 | $110.4M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Crescent Biopharma, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 9,544,262 | $13.7M | 0.50% | 00.0% | Unchanged |
| NEA Management Company, LLC | 9,089,041 | $13.1M | 0.26% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,238,553 | $3.22M | 0.00% | −21,461−0.9% | Reduced |
| Acadian Asset Management LLC | 1,951,086 | $2.81M | 0.01% | +64,999+3.4% | Added |
| BlackRock Inc. | 872,858 | $1.26M | 0.00% | −2,293−0.3% | Reduced |
| Millennium Management LLC | 691,713 | $996.0K | 0.00% | +243,703+54.4% | Added |
| Two Sigma Advisers, LP | 654,800 | $943.0K | 0.00% | +33,800+5.4% | Added |
| Two Sigma Investments, LP | 610,262 | $879.0K | 0.00% | +111,732+22.4% | Added |
| Renaissance Technologies LLC | 601,300 | $866.0K | 0.00% | +5,200+0.9% | Added |
| Dimensional Fund Advisors LP | 564,388 | $813.0K | 0.00% | −340,240−37.6% | Reduced |
| Geode Capital Management, LLC | 365,106 | $525.0K | 0.00% | −1,195−0.3% | Reduced |
| Federated Hermes, Inc. | 345,452 | $497.0K | 0.00% | +829+0.2% | Added |
| D. E. Shaw & Co., Inc. | 267,871 | $385.0K | 0.00% | −48,915−15.4% | Reduced |
| Susquehanna International Group, LLP | 265,208 | $382.0K | 0.00% | +184,857+230.1% | Added |
| Franklin Resources Inc | 160,307 | $231.0K | 0.00% | −393−0.2% | Reduced |
| Bridgeway Capital Management, LLC | 155,400 | $224.0K | 0.00% | −13,300−7.9% | Reduced |
| Gsa Capital Partners LLP | 146,078 | $210.0K | 0.03% | +146,078 | New |
| State Street Corp | 144,265 | $208.0K | 0.00% | 00.0% | Unchanged |
| Connor, Clark & Lunn Investment Management Ltd. | 119,395 | $172.0K | 0.00% | +7,097+6.3% | Added |
| Eversept Partners, LP | 100,000 | $144.0K | 0.01% | +100,000 | New |
| Northern Trust Corp | 98,487 | $142.0K | 0.00% | +621+0.6% | Added |
| Simplex Trading, LLC | 99,302 | $142.0K | 0.00% | +99,302 | New |
| Citadel Advisors LLC | 96,275 | $138.0K | 0.00% | +43,111+81.1% | Added |
| Susquehanna Fundamental Investments, LLC | 90,876 | $131.0K | 0.00% | −44,841−33.0% | Reduced |
| Intellectus Partners, LLC | 80,500 | $116.0K | 0.03% | −42,500−34.6% | Reduced |
| Morgan Stanley | 53,155 | $76.0K | 0.00% | −14,769−21.7% | Reduced |
| Ieq Capital, LLC | 38,363 | $55.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 38,533 | $55.0K | 0.00% | +12,158+46.1% | Added |
| Charles Schwab Investment Management Inc | 34,903 | $51.0K | 0.00% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 29,290 | $42.0K | 0.00% | +6,858+30.6% | Added |
| Bank of New York Mellon Corp | 26,299 | $38.0K | 0.00% | 00.0% | Unchanged |
| Algert Global LLC | 26,174 | $38.0K | 0.00% | +14,630+126.7% | Added |
| UBS Group AG | 21,054 | $30.0K | 0.00% | +21,022+65,693.8% | Added |
| Prentiss Smith & Co Inc | 14,000 | $20.0K | 0.01% | 00.0% | Unchanged |
| Bank of America Corp | 11,714 | $17.0K | 0.00% | −3,089−20.9% | Reduced |
| XR Securities LLC | 10,395 | $15.0K | 0.00% | +10,395 | New |
| Commonwealth Equity Services, LLC | 10,000 | $14.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 7,272 | $10.0K | 0.00% | +2,216+43.8% | Added |
| Bank Julius Baer & Co. Ltd, Zurich | 5,000 | $7.00K | 0.00% | 00.0% | Unchanged |
| Hartford Financial Management Inc. | 3,500 | $5.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1,238 | $2.00K | 0.00% | −29,411−96.0% | Reduced |
| FMR LLC | 1,000 | $1.00K | 0.00% | +300+42.9% | Added |
| Advisor Group Holdings, Inc. | 600 | $1.00K | 0.00% | −500−45.5% | Reduced |
| Carolinas Wealth Consulting LLC | 395 | $1.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 481 | $693 | 0.00% | −61−11.3% | Reduced |
| Wells Fargo & Company | 254 | $0 | 0.00% | +1+0.4% | Added |
| FinTrust Capital Advisors, LLC | 245 | $0 | 0.00% | +245 | New |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −365,013−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −54,147−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −51,284−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −31,800−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −4,819−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |